Sue Cheeseman
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 4
- Advanced Breast Cancer Therapies 2
- Gastric Cancer Management and Outcomes 2
- Oncology 9
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 3
- Co-authors
- Malcolm Ranson (3 shared papers)J. Margison (2 shared papers)Shane White (1 shared paper)Anthony Howell (1 shared paper)Will Sopwith (10 shared papers)Matthew D. Thompson (11 shared papers)Geoff Hall (11 shared papers)Laure Lacoin (8 shared papers)
- Journals
- BMJ Open (3 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Journal of Thoracic Oncology (2 papers)ESMO Open (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Sue Cheeseman
22 papers receiving 179 citations
Peers
Comparison fields: 5 of 47
- Biomaterials 33
- Oncology 56
- Pulmonary and Respiratory Medicine 61
- Geriatrics and Gerontology 4
- Health Informatics 1
Countries citing papers authored by Sue Cheeseman
This map shows the geographic impact of Sue Cheeseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Cheeseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Cheeseman more than expected).
Fields of papers citing papers by Sue Cheeseman
This network shows the impact of papers produced by Sue Cheeseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Cheeseman. The network helps show where Sue Cheeseman may publish in the future.
Co-authors
The 25 scholars most cited alongside Sue Cheeseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 37 | |
| 2 | Phase II study of oral topotecan in advanced non-small cell lung cancer. | 2000 | 28 |
| 3 | 2017 | 27 | |
| 4 | 1996 | 23 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 11 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2018 | 4 | |
| 11 | 2018 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2018 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2012 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2024 | 1 |
About Sue Cheeseman
Sue Cheeseman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Cancer Research and Molecular Biology, having authored 23 papers that have together received 182 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Multiple and Secondary Primary Cancers (2 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Breast Cancer Therapies (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Biomaterials (33 citations), Oncology (56 citations), Pulmonary and Respiratory Medicine (61 citations), Geriatrics and Gerontology (4 citations) and Health Informatics (1 citation). Sue Cheeseman has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Malcolm Ranson, J. Margison, Shane White, Anthony Howell, Will Sopwith, Matthew D. Thompson, Geoff Hall, Laure Lacoin, Bernadette M. Carrington and M. Daumont. Their work appears in journals such as BMJ Open, Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.